SU1318149A3 - Способ получени вакцины против таежного весенне-летнего энцефалита - Google Patents

Способ получени вакцины против таежного весенне-летнего энцефалита Download PDF

Info

Publication number
SU1318149A3
SU1318149A3 SU792854825K SU2854825K SU1318149A3 SU 1318149 A3 SU1318149 A3 SU 1318149A3 SU 792854825 K SU792854825 K SU 792854825K SU 2854825 K SU2854825 K SU 2854825K SU 1318149 A3 SU1318149 A3 SU 1318149A3
Authority
SU
USSR - Soviet Union
Prior art keywords
virus
fractions
carried out
vaccine against
ultracentrifugation
Prior art date
Application number
SU792854825K
Other languages
English (en)
Russian (ru)
Inventor
Хайнц Франц
Кунц Кристиан
Фаума Йоханн
Шварц Отто
Original Assignee
Иммуно Аг Фюр Хемиш-Медицинише Продукте (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Иммуно Аг Фюр Хемиш-Медицинише Продукте (Фирма) filed Critical Иммуно Аг Фюр Хемиш-Медицинише Продукте (Фирма)
Application granted granted Critical
Publication of SU1318149A3 publication Critical patent/SU1318149A3/ru

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B28—WORKING CEMENT, CLAY, OR STONE
    • B28D—WORKING STONE OR STONE-LIKE MATERIALS
    • B28D1/00—Working stone or stone-like materials, e.g. brick, concrete or glass, not provided for elsewhere; Machines, devices, tools therefor
    • B28D1/02—Working stone or stone-like materials, e.g. brick, concrete or glass, not provided for elsewhere; Machines, devices, tools therefor by sawing
    • B28D1/06—Working stone or stone-like materials, e.g. brick, concrete or glass, not provided for elsewhere; Machines, devices, tools therefor by sawing with reciprocating saw-blades
    • B28D1/068—Components, e.g. guiding means, vibrations damping means, frames, driving means, suspension
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Mechanical Engineering (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Mining & Mineral Resources (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SU792854825K 1978-12-22 1979-12-21 Способ получени вакцины против таежного весенне-летнего энцефалита SU1318149A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT922078A AT358167B (de) 1978-12-22 1978-12-22 Verfahren zur herstellung von fruehsommer- -meningoenzephalitis-virus (fsme-virus)- -vakzinen

Publications (1)

Publication Number Publication Date
SU1318149A3 true SU1318149A3 (ru) 1987-06-15

Family

ID=3612255

Family Applications (2)

Application Number Title Priority Date Filing Date
SU792854825A SU1003738A3 (ru) 1978-12-22 1979-12-21 Способ получени вакцины таежного весенне-летнего энцефалитного вируса
SU792854825K SU1318149A3 (ru) 1978-12-22 1979-12-21 Способ получени вакцины против таежного весенне-летнего энцефалита

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SU792854825A SU1003738A3 (ru) 1978-12-22 1979-12-21 Способ получени вакцины таежного весенне-летнего энцефалитного вируса

Country Status (11)

Country Link
AT (1) AT358167B (fr)
BE (1) BE880732A (fr)
CH (1) CH644271A5 (fr)
CS (1) CS223975B2 (fr)
DE (1) DE2950004C2 (fr)
FR (1) FR2444466A1 (fr)
GB (1) GB2038179B (fr)
IT (1) IT1126676B (fr)
SE (1) SE447789B (fr)
SU (2) SU1003738A3 (fr)
YU (1) YU42204B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT384363B (de) * 1982-10-05 1987-11-10 Immuno Ag Verfahren zur verwendung von antigenreaktiven peptiden zur herstellung von gegen fsme-virusinfektionen wirksamen vakzinen
AT385203B (de) * 1985-04-26 1988-03-10 Immuno Ag Verfahren zur herstellung einer fruehsommermeningoenzephalitis-virus (fsme-virus)-vakzine
AT393356B (de) * 1989-12-22 1991-10-10 Immuno Ag Verfahren zur herstellung von fsme-virus-antigen
US5719051A (en) * 1989-12-22 1998-02-17 Immuno Aktiengesellschaft Perfusion system and a method for the large scale production of virus or virus antigen
AT393277B (de) * 1990-01-04 1991-09-25 Immuno Ag Verfahren zur herstellung von fruehsommer- meningoenzephalitis-virus (fsme-virus)-antigen
IT1305405B1 (it) * 1998-02-18 2001-05-04 Augusto Cappelli Telaio di taglio per la segagione di blocchi di pietra, roccia,granito, marmo, o simili.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1152626A (en) * 1967-07-07 1969-05-21 Merck & Co Inc Rubella Vaccine
GB1453035A (en) * 1972-12-21 1976-10-20 Secr Defence Virus vaccine production

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Патент GB № 453035. кл. А5В, 1977. Авторское свидетельство СССР № 660389, кл. С 12 N 7/04, 1977, *

Also Published As

Publication number Publication date
GB2038179B (en) 1983-02-16
CH644271A5 (de) 1984-07-31
AT358167B (de) 1980-08-25
YU311779A (en) 1983-10-31
DE2950004C2 (de) 1991-04-18
IT1126676B (it) 1986-05-21
SE7910054L (sv) 1980-06-23
YU42204B (en) 1988-06-30
SE447789B (sv) 1986-12-15
FR2444466A1 (fr) 1980-07-18
GB2038179A (en) 1980-07-23
IT7928341A0 (it) 1979-12-21
FR2444466B1 (fr) 1983-07-08
CS223975B2 (en) 1983-11-25
ATA922078A (de) 1980-01-15
SU1003738A3 (ru) 1983-03-07
BE880732A (fr) 1980-04-16
DE2950004A1 (de) 1980-07-03

Similar Documents

Publication Publication Date Title
Laidlaw Virus diseases and viruses
US7846685B2 (en) Methods and compositions for the control of coccidiosis
SU1318149A3 (ru) Способ получени вакцины против таежного весенне-летнего энцефалита
RU2125890C1 (ru) Способ вакцинации in ovo против кокцидиоза
US3874999A (en) Process for the purification of virus vaccine
CN106727623B (zh) 海藻低聚糖在制备抗禽白血病病毒制剂中的应用
JP7232772B2 (ja) 抗生物質を含まないコクシジウム症の予防又は制御のための組成物
MCGHEE et al. Axenic cultivation of Phytomonas davidi Lafont (Trypanosomatidae), a symbiote of laticiferous plants (Euphorbiaceae)
JP2019512456A (ja) Ｖｈｓｖワクチン及びアジュバントを含有するワクチン組成物
DD300833A7 (de) Verfahren zur herstellung von inaktivierten influenza-vollvirusimpfstoffen
CN106282240B (zh) 构建稳定高效表达c-met蛋白的大鼠骨髓间充质干细胞细胞株的方法
CN104587274B (zh) 一种竹叶异荭草素提取物
CN109369784B (zh) PaTx-1毒素及其应用
JP6161183B1 (ja) 記憶改善用ペプチド
YAMAOKA et al. Scale formation in an amoeba, Cochliopodium sp.
RU2222337C1 (ru) Способ получения иммуностимулятора
Ohta et al. Initiation of cleavage in fish eggs by injection of flagella or microtubules of sea urchin spermatozoa
Hansen Cultivation of Eimeria dispersa in bobwhite quail embryos
Polson The particle size of bluetongue virus as determined by ultrafiltration and ultracentrifugation
KR102622408B1 (ko) Opa1 억제에 의한 조골세포 활성화를 통한 골형성 촉진 유도용 또는 골질환 치료용 조성물
RU2225223C1 (ru) Лиофилизированная антигерпетическая вакцина
IL29444A (en) Method for the preparation of vaccines from viruses of the influenza group
RU2720689C1 (ru) Способ получения напитка
Michel A Study of Toxins and the Serological Reactions in Sprue.
US10660925B2 (en) Method for producing a medium containing steroidal glycosides from plant cells of the genus Hoodia